$PIRS gets $13m MS from $AZN for starting P2a; AZN also makes $10m equity investment. $PIRS to present updated data for PRS-343 at AACR; P2 to begin 3Q21. $SGEN made $13m equity investment in PIRS & arranged a trial of tucatinib & PRS-343 in gastric ca pts.
Savara, Aquestive Therapeutics Shares Spike To Session High As TipRanks Tweets '2 "Strong Buy" Penny Stocks That Could Go Boom' $AQST $SVRA https://t.co/ybLDQNbVeq